The professor was honoured at the 40 th Asia-Pacific Academy of Ophthalmology (APAO) Congress held in conjunction with the 83 rd Annual Conference of the All India Ophthalmological Society (AIOS) ...

BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Ace Vision Group, Inc. ("AVG” or "the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical trials among patients with presbyopia. Tenpoint Therapeutics announced the ...

NDA submission includes efficacy and safety data for the first fixed-dose combination therapy from the world’s largest and longest study ever conducted in the presbyopia eye drop category ...

If approved, Brimochol PF would be the first combination therapy for presbyopia. Perspective from Michael DeCourcey, MD Tenpoint Therapeutics submitted a new drug application to the FDA for ...

BRIMOCHOL PF combines brimonidine and carbachol, enhancing depth of focus and efficacy for presbyopia treatment. Positive phase 3 trial data showed significant near vision improvements and a favorable ...

NDA submission includes efficacy and safety data for the first fixed-dose combination therapy from the world’s largest and longest study ever conducted in the presbyopia eye drop category “The ...

Alzheimer’s Association Quality Control (QC) Program brings together laboratories across the globe with the aim of standardizing the measurement of Alzheimer's biomarkers. The program aims to monitor ...

Qlosi eye drops offer a novel presbyopia treatment, enhancing near vision with flexible dosing and minimal side effects. The EyeQ formulation balances pilocarpine concentration and pH for optimal ...

To assess visual performance and overall satisfaction with EDOF CLs, Kamiya and colleagues conducted a prospective study in 42 eyes of 21 subjects with presbyopia. They assessed visual acuity at ...